generics

Teva’s generic label not skinny enough to protect from $234M damages to GSK
MedCity News
Sat, 08/7/21 - 11:57 pm
Teva Pharmaceutical
generics
labeling
patents
GSK
Coreg
Kaiser Sues Merck, Generic Drug Firm Over Millions in Losses Due to Alleged "Pay-for-Delay" Scheme
BioSpace
Thu, 07/29/21 - 11:08 pm
Merck
Kaiser Permanente
generics
pay-for-delay
Zetia
Vytorin
Biden wants to bolster the pharma supply chain. A major generic plant closing may make that harder
Stat
Tue, 07/27/21 - 10:24 am
generics
drug manufacturing
Joe Biden
supply chain
Viatris
Fight over “pay for delay” heats up in Washington
MedCity News
Thu, 07/22/21 - 10:17 pm
pay-for-delay
generics
innovation
legislation
Cost-cutting generics and biosimilars stuck in legal limbo
MedCity News
Thu, 07/22/21 - 10:58 am
generics
biosimilars
drug pricing
patents
Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats
Fierce Pharma
Thu, 07/1/21 - 11:08 pm
Teva Pharmaceutical
Mylan
Viatris
MS
generics
Copaxone
Viatris scores a win in long-running EpiPen antitrust lawsuit, but patent settlement charge heads to trial
Fierce Pharma
Fri, 06/25/21 - 11:09 am
EpiPen
generics
Mylan
Viatris
antitrust
Teva to Settle Mississippi Drug-Price Case, Seek More Pacts
Bloomberg
Wed, 06/23/21 - 10:34 am
Teva Pharmaceutical
Mississippi
generics
price fixing
Bristol Myers inks another Revlimid patent settlement—this time with Sun Pharma—as copycats near
Fierce Pharma
Tue, 06/22/21 - 10:49 pm
Bristol Myers Squibb
Celgene
Revlimid
generics
Sun Pharma
patents
Law banning copay coupons didn't boost generic drug use, study finds
Beckers Hospital Review
Mon, 06/21/21 - 10:21 pm
generics
copay coupons
California
FDA launches global Generic Drug Cluster
RAPS.org
Mon, 06/14/21 - 11:59 pm
FDA
generics
regulatory
Seven insurers sue CVS for allegedly inflating drug prices
MedCity News
Fri, 05/28/21 - 11:21 am
CVS Health
insurers
drug pricing
generics
FDA releases batch of 21 product-specific guidances
RAPS.org
Wed, 05/19/21 - 11:21 pm
FDA
regulatory
generics
Novartis' Sandoz embarks on €150M antibiotics manufacturing upgrade in Europe
Fierce Pharma
Tue, 05/18/21 - 11:01 am
Novartis
Sandoz
generics
Europe
drug manufacturing
Sandoz's Enbrel biosim case turned away at SCOTUS, giving Amgen's blockbuster 8 more years of free rein
Fierce Pharma
Mon, 05/17/21 - 10:59 pm
Novartis
Sandoz
generics
Supreme Court
Amgen
Embrel
biosimilar
Vaccine waiver talks can make drug firms the heroes, U.S. trade chief says
Reuters
Fri, 05/14/21 - 12:01 am
vaccines
COVID-19
intellectual property
generics
FDA welcomes alternative approaches to generic drug development
RAPS.org
Wed, 05/5/21 - 09:57 pm
generics
FDA
CDER
drug development
FDA issues 36 new and revised product-specific guidances
RAPS.org
Thu, 03/25/21 - 10:49 pm
FDA
generics
bioequivalence
Alembic pulls blood pressure generic after complaint reveals labeling mix-up
Fierce Pharma
Thu, 03/25/21 - 11:50 am
generics
Alembic Pharmaceuticals
telmisartan
product recalls
Teva sees room for growth with FDA communications and complex generics, COO says
Endpoints
Wed, 03/24/21 - 11:13 pm
Teva Pharmaceutical
generics
FDA

Pages